Prasol Chemicals IPO Allotment Expected Today: Check Your Status, GMP, and Key Details!
Investors are eagerly anticipating the allotment update for the Prasol Chemicals IPO, which was subscribed 3.47 times overall. The IPO, valuing at Rs 500 crore, opened for subscription on September 8, 2026, and closed on September 10, 2026. The share allotment is expected to be finalized today, with public listings scheduled on the BSE and NSE for September 16, 2026. The retail investor portion saw a subscription rate of 1.79 times, while non-institutional investors subscribed 1.89 times and qualified institutional buyers (QIBs) oversubscribed their portion at 7.59 times.
Currently, the grey market sentiment reflects minimal enthusiasm, with Prasol Chemicals showing no grey market premium (GMP). This suggests a potentially flat listing on the stock market, although it is worth noting that GMP is not a definitive measure and can fluctuate leading up to the share debut. Given the mixed subscription figures across different investor categories, early indicators of demand might lead to varying interpretations among retail investors regarding the company’s immediate future.
The performance metrics released by Prasol Chemicals prior to the IPO are promising, showcasing a 22% hike in total income and a remarkable 91% increase in profit after tax year-on-year. For Indian investors, particularly retail participants, this IPO offers a glimpse into the speciality chemicals sector, with Prasol having a diverse range of products and a robust global market presence. The awaited allotment results could set the stage for investor confidence in upcoming IPOs, depending on whether the company’s initial market performance aligns with its financial optimism.
• WEALTHOVA INSIGHTS
Investors should prepare for cautious trading as Prasol Chemicals’ initial listing may reflect sentiment from the grey market. Positive financial growth could, however, pivot investor attention towards long-term prospects in the speciality chemicals sector.
Disclaimer: Market insights and analyses on Wealthova are strictly for educational and informational purposes and do not constitute financial or investment advice. Please consult a SEBI-registered financial advisor before making investment decisions.
Source: The Economic Times
(Expert Note: This report was prepared by the Wealthova IPO team.)

